Metraipolis › archive › dc_4fcee7224897

COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant… — Europe PMC PMID:41749920

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41749920
DOI
10.3390/cancers18040667
License (as archived)
solo-consultazione
Archived
2026-10-08T17:15:13.906Z
SHA-256 of the archived text
655c9d142b6dde6b20ecda956d0de9a30e5156a308176ef76521306c43d552bc
Stable URL of this page
https://metraipolis.com/documento/dc_4fcee7224897

How to cite

COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant… — Europe PMC PMID:41749920 — Europe PMC (en), https://europepmc.org/article/MED/41749920 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4fcee7224897 (Metraipolis archive dc_4fcee7224897, sha256 655c9d142b6dde6b20ecda956d0de9a30e5156a308176ef76521306c43d552bc)
BibTeX
@misc{dc4fcee7224897,
  title = {COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant… — Europe PMC PMID:41749920},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41749920},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4fcee7224897; sha256 655c9d142b6dde6b20ecda956d0de9a30e5156a308176ef76521306c43d552bc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41749920. Agents can read the archived copy with the MCP tool read_document.